Preclinical memory decline in cognitively normal apolipoprotein E-ε4 homozygotes

Neurology

Volumn 53, Issue 1, 1999, Pages 201-207

  Caselli, Richard J ^a   Graff Radford, N R ^b   Reiman, E M ^c   Weaver, A ^a   Osborne, D ^a   Lucas, J ^b   Uecker, A ^d   Thibodeau, S N ^e  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0033551459     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.1.201     Document Type: Article

References (39)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
3. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995;183:32-34.
4. Dal Forno G, Rasmusson DX, Brandt J, et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996;53:345-350.
5. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
6. Kurz A, Egensperger R, Haupt M, et al. Apolipoprotein E ∈4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996;47:440-443.
7. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47: 444-448.
8. Craft S, Teri L, Edland SD, et al. Accelerated decline in apolipoprotein E ∈4 homozygotes with Alzheimer's disease. Neurology 1998;51:149-153.
9. Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer LJ. Association between apolipoprotein E ∈4 and the rate of cognitive decline in community-dwelling individuals with and without dementia. Arch Neurol 1998;55:1065-1069.
10. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the ∈4 allele for apolipoprotein E. N Engl J Med 1996;34:752-758.
11. Reiman EM, Uecker A, Caselli RJ, et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998;44:288-291.
12. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy DJ. Preclinical evidence of Alzheimer's disease in persons heterozygous for the epsilon 4 allele for apolipoprotein E. Presented at the 4th annual Robert S. Flinn Foundation Symposium; Tucson, AZ; December 1998.
13. Reed T, Carmelli D, Swan GE, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ∈4 allele. Arch Neurol 1994;51:1189-1192.
14. Jacobs DM, Sano M, Dooneif G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurol 1995;45:957-962.
15. Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the apoE-∈4 allele in nondemented older adults. Neurology 1995;45:2203-2206.
16. Tierny MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661-665.
17. Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: a longitudinal prospective study. Brain 1998;121:1631-1639.
18. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
19. Becker JT. Working memory and secondary memory deficits in Alzheimer's disease. J Clin Exp Neuropsychol 1988;10:739-753.
20. Morris RG. Short-term forgetting in senile dementia of the Alzheimer's type. Cogn Neuropsychol 1986;3:77-97.
21. Wilson RS, Bacon LD, Fox JH, Kaszniak AW. Primary memory and secondary memory in dementia of the Alzheimer type. J Clin Neuropsychol 1983;5:337-344.
22. Baddeley A, Logie R, Bressi S, Delia Sala S, Spinnler H. Dementia and working memory. Q J Exp Psychol 1986;38A: 603-618.
23. Hixson JE, Vernier DT. Restriction isotypmg of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-548.
24. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health work group. Dev Neuropsychol 1986;2:261-276.
25. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
27. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and education level. JAMA 1993;269:2386-2391.
28. Lezak MD. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1983.
29. Ivnik RJ, Malec JF, Tangalos EG, Petersen RC, Kokmen E, Kurland LT. Mayo's older American's normative studies: updated AVLT norms for ages 56 to 97. Clin Neuropsychol 1992; 6:S83-S104.
30. Baddeley AD, Warrington EK. Amnesia and the distinction between long and short term memory. J Verb Learn Verb Behav 1970;9:176-189.
31. D'Esposito M, Detre J, Alsop D, et al. The neural basis of the central executive system of working memory. Nature 1995; 378:279-281.
32. Goldman-Rakic PS. Working memory and the mind. Sci Am 1992;267:111-117.
33. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950-2967.
34. Light LL, Anderson PA. Working-memory capacity, age, and memory for discourse. J Gerontol 1985;40:737-747.
35. Craik FIM, McDowd JM. Age differences in recall and recognition. J Exp Psychol 1987;13:474-479.
36. de Leon MJ, George AE, Tomanelli J, et al. Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET IV and 11-CDG. Neurobiol Aging 1987;8:319-323.
37. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995;36:1141-1149.
38. Uecker A, Lewis S, McGauhey CA, et al. Whole brain, ventricular, and frontal lobe cerebral spinal fluid volumes in apolipoprotein E type 4 homozygotes before the onset of Alzheimer's dementia. Soc Neurosci Abstracts 1998;24:210. Abstract.
39. Troncoso JC, Cataldo AM, Nixon RA, et al. Neuropathology of preclinical and clinical late onset Alzheimer's disease. Ann Neurol 1998;43:673-676.